Vimarsana
Biggest News Aggregation in the World

Michael Kappelman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Kappelman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Kappelman Today - Breaking & Trending Today

Clinical Challenges: Managing Pediatric Crohn's Disease - Vimarsana News

Clinical Challenges: Managing Pediatric Crohn's Disease

Kids' growth and psychological health compete with treatment goals

Low Uptake of Treat-to-Target Endoscopic Monitoring in IBD - Vimarsana News

Low Uptake of Treat-to-Target Endoscopic Monitoring in IBD

Only about half of patients with inflammatory bowel disease (IBD) undergo colonoscopy in the 3 to 15 months after starting a new IBD treatment, even though the procedure is widely recommended.

Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit - Vimarsana News

Pediatric Crohn's: Adalimumab+Methotrexate Offers Strong Benefit

A landmark trial suggests adding low-dose methotrexate should be strongly considered in children with Crohn's disease who are starting adalimumab.

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease - Vimarsana News

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease

Crohn's disease is a lifelong inflammatory bowel disease (IBD) that is characterized by swelling in the lining of the digestive tract, causing severe diarrhea, abdominal pain, and rectal bleeding.

Robust Immune Response After COVID Boosters in Those With IBD - Vimarsana News

Robust Immune Response After COVID Boosters in Those With IBD

Researchers behind the study suggest the findings could apply to others who are immunosuppressed.